The following table provides an overview of the latest patents of Sanofi Biotechnology that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3110848Feb 14, 2024Methods For Treating Skin Infection By Administering An Il-4R Antagonist5
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor7
EP3973987Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP4011915Nov 15, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP3703818Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist7
EP3470432Oct 6, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist4
EP3107575Sep 1, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist3
EP2892927May 9, 2018Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist1